Stem Cell Therapy Opens New Hope for Modern Treatment

In order to find ways to treat diseases, research on treatment methods is widely conducted and is accelerating. For this purpose, there are many areas of research, including stem cell therapy, which is one of the most attractive and active areas in the world. Due to the self-renewal and differentiation potential of stem cells, it is a new hope for modern therapies. The first successful case of human stem cell therapy was reported in 1959. Bone marrow repair was observed in leukemic patients who underwent whole body irradiation after intravenous injection of twin bone marrow (Thomas et al., 1957).

In recent years, stem cell therapy is very popular in modern medicine and therapeutics. Stem cells are cells that can infinitely divide and produce specialized cells during culture. The method that stem cell regeneration is used to repair and treat muscle and tissue damage is a revolution. Stem cells are very promising to help us understand and treat various diseases, injuries and other health related diseases. However, there are still plenty of places to learn about stem cells, and many other conditions are under study. In addition, researchers are continuing to look for new ways to use stem cells in medicine. Stem cell therapy, called a lack of consciousness or concern about new research, has some myths and misunderstandings due to what we are about to end:

Stem cell therapy is an effective therapy in regenerative medicine and is a new way to overcome the limitations of currently available therapies. Stem cell therapy can now be used to treat MS worldwide. However, depending on each regulation and policy, treatment costs vary from country to country. In the United States, the average cost per treatment is $ 7,000 to $ 10,000. Treatment expenses outside the United States are usually much higher than the US, ranging from $ 20,000 to $ 100,000. In a cost-effectiveness study of UK MS treatment AHSC transplant conducted by Tappenden et al., Cost-effective AHSC transplantation is expected to cost about 2,800 pounds per year after additional quality adjustment 39.

Currently, stem cell-based therapy is a clinical treatment standard for several symptoms, such as hematopoietic stem cell transplantation for leukemia and epithelial stem cell-based therapy for burn and corneal disorders. However, the general population may not understand the long-standing preclinical and clinical research necessary to establish new stem cell therapy. Unfortunately, some malignant clinicians around the world are taking advantage of patient hope by claiming to provide effective stem cell therapy for significant money. These so-called "stem cell clinics" raise allegations about the stem cell therapy they provide without reliable reasons, transparency, supervision or patient protection (29).